Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Over-the-Counter

Aurobindo Pharma USA Inc.: Fluent Children's Ibuprofen Oral Suspension Recalled Due to Missing Dosing Cups

Agency Publication Date: November 5, 2020
Share:
Sign in to monitor this recall

Summary

Aurobindo Pharma USA Inc. is recalling 7,440 bottles of Fluent Children's Fever + Pain Ibuprofen Oral Suspension (100 mg per 5 mL) because the product is missing the required dosing cups. This berry-flavored medication, sold in 4-ounce bottles, was distributed by Chalkboard Health Inc. and manufactured in India. Without the dosing cup, there is a risk that caregivers may use an incorrect measuring device, leading to inaccurate dosing of the medication for children. Consumers should check their medicine cabinets for the affected bottles and contact their healthcare provider or pharmacist for guidance.

Risk

The absence of the included dosing cup significantly increases the risk of a medication error, as caregivers may use household spoons or other non-standard measuring tools that do not provide the precise 5 mL measurement required. This could lead to under-dosing or over-dosing the child, potentially causing ineffective treatment or adverse side effects from too much ibuprofen.

What You Should Do

  1. Check your medicine cabinet for 4 fl oz (120 mL) bottles of 'Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL' in Berry Flavor.
  2. Verify the bottle's label for NDC 79395-003-92 and look for Lot # BO1020080AA3 with an expiration date of 7/2023.
  3. If you have an affected bottle and it is missing its dosing cup, do not attempt to guess the dose using household spoons or other unverified measuring devices.
  4. Contact your healthcare provider or pharmacist for guidance regarding the use of this product and potential dose measurement concerns.
  5. Return any unused product to the place of purchase for a refund and contact Aurobindo Pharma USA Inc. for further instructions.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare consultation and refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL, Berry Flavor (4 fl oz)
Model:
NDC 79395-003-92
Lot Numbers:
BO1020080AA3 (Exp 7/2023)
Date Ranges: Expiration Date 7/2023

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 86567
Status: Resolved
Manufacturer: Aurobindo Pharma USA Inc.
Sold By: Chalkboard Health Inc.; getfluenthealth.com
Manufactured In: India
Units Affected: 7440 bottles
Distributed To: New Jersey

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.